BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38013282)

  • 1. MYLK and CALD1 as molecular targets in bladder cancer.
    Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
    Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
    Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
    Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.
    Liu Y; Wu X; Wang G; Hu S; Zhang Y; Zhao S
    Medicine (Baltimore); 2019 Jan; 98(2):e13847. PubMed ID: 30633156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.
    Su Q; Dai B; Zhang H; Zhang S
    Comput Math Methods Med; 2022; 2022():8430485. PubMed ID: 35799671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.
    Tan X; Chen M
    Tumour Biol; 2014 Dec; 35(12):12189-200. PubMed ID: 25179839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
    Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X
    Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAV1 and KRT5 are potential targets for prostate cancer.
    Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
    Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD14 and CSF1R in osteoarthritis and gastritis.
    Zheng M; Li Z; Feng Y; Hou S; Zhang J; Kang C
    Medicine (Baltimore); 2023 Oct; 102(43):e35567. PubMed ID: 37904379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RRP9 and DDX21 as new biomarkers of colorectal cancer.
    Chi X; Yang N; Liu Y
    Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3D and CD247 are the molecular targets of septic shock.
    Yang Q; Feng Z; Ding D; Kang C
    Medicine (Baltimore); 2023 Jul; 102(29):e34295. PubMed ID: 37478215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of DSCC1 and GINS1 in gastric cancer.
    Hou S; Zhang J; Chi X; Li X; Zhang Q; Kang C; Shan H
    Medicine (Baltimore); 2023 Oct; 102(43):e35681. PubMed ID: 37904396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.
    Zhang L; Liu B; Su J
    Medicine (Baltimore); 2023 Feb; 102(6):e32825. PubMed ID: 36820589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis.
    Tan Y; Ma Y; Guo S; Lin Y
    Medicine (Baltimore); 2024 Jan; 103(1):e36868. PubMed ID: 38181234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.
    Ning X; Deng Y
    Onco Targets Ther; 2017; 10():1673-1686. PubMed ID: 28356754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis.
    Zhao M; Liu A; Mo L; Wan G; Lu F; Chen L; Fu S; Chen H; Fu T; Deng H
    Medicine (Baltimore); 2023 Oct; 102(42):e34445. PubMed ID: 37861500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fgf2 and Ptpn11 play a role in cerebral injury caused by sevoflurane anesthesia.
    Zhang L; Xu L
    Medicine (Baltimore); 2023 Nov; 102(45):e36108. PubMed ID: 37960778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TOP2A and CDC6 in liver cancer.
    Jia W; Liu X; Zhang Z
    Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercellular adhesion molecule 1 and selectin l play crucial roles in ulcerative colitis.
    He J; Ni Z; Li Z
    Medicine (Baltimore); 2023 Dec; 102(49):e36552. PubMed ID: 38065859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics.
    Liu J; Wu P; Lai S; Wang J; Wang J; Zhang Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16885-16904. PubMed ID: 37740761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.